Published in Eur J Pharmacol on January 12, 1998
Neuropeptides activate human mast cell degranulation and chemokine production. Immunology (2007) 1.56
Acute restraint stress activates functional NK1 receptor in the colon of female rats: involvement of steroids. Gut (2002) 0.82
Inhibition of GTPase activity of Gi proteins and decreased agonist affinity at M2 muscarinic acetylcholine receptors by spermine and methoctramine. Br J Pharmacol (1999) 0.77
Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol (2016) 0.77
GAIP, a protein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain. Proc Natl Acad Sci U S A (1995) 2.33
G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci (1990) 2.32
[Neuropeptides and inflammation: presumed mechanisms in neurogenic inflammation]. Pathol Biol (Paris) (1990) 1.98
ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res (2000) 1.51
Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center. J Biol Chem (2000) 1.42
Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett (1990) 1.37
Activation of rat peritoneal mast cells by substance P and mastoparan. J Pharmacol Exp Ther (1989) 1.23
Can calmodulin inhibitors be used to probe calmodulin effects? Biochem Pharmacol (1981) 1.23
Airway epithelium releases a relaxant factor: demonstration with substance P. Eur J Pharmacol (1986) 1.15
Arachidonic acid metabolites and airway epithelium-dependent relaxant factor. J Pharmacol Exp Ther (1987) 1.13
Natural polyamines stimulate G-proteins. Biochem J (1992) 1.10
Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology (1994) 1.08
Sodium-potassium ATPase, calcium, and immunological histamine release. Biochem Pharmacol (1983) 1.07
Characterization of muscarinic receptors in human, guinea pig and rat lung. J Pharmacol Exp Ther (1989) 1.05
Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol Lett (1990) 1.04
A mechanism of action for anaphylatoxin C3a stimulation of mast cells. J Immunol (1992) 1.04
Sodium-potassium ATPase inhibition potentiates compound 48/80-induced histamine secretion from mast cells. Br J Pharmacol (1984) 1.01
Effect of Hoe 140, a new B2 noncompetitive antagonist, on guinea pig tracheal bradykinin receptors. J Pharmacol Exp Ther (1992) 1.00
Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br J Pharmacol (1981) 1.00
Comparative action of new highly potent bradykinin receptor antagonists in the guinea-pig trachea. Eur J Pharmacol (1993) 0.99
Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med (1985) 0.97
Muscarinic receptor subtypes in guinea pig airways. Am J Physiol (1991) 0.96
Transport of calcium ions by Ehrlich ascites-tumour cells. Biochem J (1976) 0.95
Lanthanides are transported by ionophore A23187 and mimic calcium in the histamine secretion process. Br J Pharmacol (1983) 0.95
Plasma membrane fluidity studies by fluorescence polarization in rat mast cells stimulated by compound 48/80. Agents Actions (1985) 0.94
A fluorescent hydrophobic probe used for monitoring the kinetics of exocytosis phenomena. Biochemistry (1986) 0.93
Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells. Mol Pharmacol (1990) 0.92
Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet. Biochim Biophys Acta (1987) 0.91
Activation of CD47 receptors causes histamine secretion from mast cells. Cell Mol Life Sci (2009) 0.90
Evidence for two high-affinity bradykinin binding sites in the guinea-pig lung. Eur J Pharmacol (1991) 0.90
Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions (1985) 0.90
Oligomycin resistance of mitochondrial adenosine triphosphatase in a pleiotropic chromosomal mutant of a "petite-negative" yeast, Schizosaccharomyces pombe. J Biol Chem (1973) 0.89
Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds. Biochem Pharmacol (1981) 0.88
Interleukin-1beta induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells. Mol Pharmacol (1998) 0.88
Calcium dependent modulation of histamine release from mast cells by sodium and potassium. Agents Actions (1985) 0.88
Toxoplasma gondii-induced foetal resorption in mice involves interferon-gamma-induced apoptosis and spiral artery dilation at the maternofoetal interface. Int J Parasitol (2008) 0.88
The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway. Biochim Biophys Acta (1993) 0.88
Flavonoids are selective cyclic GMP phosphodiesterase inhibitors. Biochem Pharmacol (1979) 0.87
[Type E botulism. 2 epidemics at Fort Chimo]. Union Med Can (1973) 0.86
Transmembrane sodium and potassium gradients modulate histamine secretion induced by ionophore A23187. Br J Pharmacol (1985) 0.86
Muscarinic acetylcholine receptor: thermodynamic analysis of the interaction of agonists and antagonists. Biochim Biophys Acta (1986) 0.85
Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential. Fundam Clin Pharmacol (2000) 0.84
Resting plasma membrane potential of rat peritoneal mast cells is set predominantly by the sodium pump. FEBS Lett (1989) 0.84
Modifications of mitochondrial ATPase in chromosomal respiratory-deficient mutants of a "petite-negative" yeast: Schizosaccharomyces Pombe 972h. Biochem Biophys Res Commun (1972) 0.84
Cellular and molecular physiopathology of congenital toxoplasmosis: the dual role of IFN-gamma. Parasitology (2007) 0.83
Drugs interacting with G protein alpha subunits: selectivity and perspectives. Fundam Clin Pharmacol (1998) 0.83
Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors. Br J Pharmacol (1999) 0.83
Labelling of the inner side of granules membrane during exocytosis. A method to differentiate secretion processes. Agents Actions (1986) 0.81
Isoleucine 10 is essential for DNA gyrase B function in Escherichia coli. Biochimie (1999) 0.81
Molecular differentiation of Entamoeba histolytica and Entamoeba dispar from Tunisian food handlers with amoeba infection initially diagnosed by microscopy. Parasite (2008) 0.80
Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli. Eur J Pharmacol (1995) 0.79
Advanced glycation end products (AGEs) activate mast cells. Br J Pharmacol (2010) 0.79
Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors. Biochem Biophys Res Commun (1988) 0.79
Mast cell activation involves plasma membrane potential- and thapsigargin-sensitive intracellular calcium pools. Fundam Clin Pharmacol (1995) 0.79
Separation of three cyclic-nucleotide-phosphodiesterases from bovine aorta. Biochem Biophys Res Commun (1978) 0.79
Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea-pig trachea. Eur J Pharmacol (1992) 0.79
Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists. J Neurol Sci (1990) 0.79
Effect of WIN 64338, a B2 bradykinin receptor antagonist on guinea-pig tracheal smooth muscle cells in culture. Fundam Clin Pharmacol (1998) 0.79
Temperature-dependence and heterogeneity of muscarinic agonist and antagonist binding. Biochem Pharmacol (1987) 0.78
Physiological and genetic modifications of the expression of the yeast mitochondrial adenosine triphosphatase inhibitor. Biochim Biophys Acta (1975) 0.78
PLA2 phosphorylation and cyclooxygenase-2 induction, through p38 MAP kinase pathway, is involved in the IL-1beta-induced bradykinin B2 receptor gene transcription. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.78
Evidence for the involvement of calcitonin gene-related peptide in the epithelium-dependent contraction of guinea-pig trachea in response to capsaicin. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.78
The role of the sodium pump in the plasma membrane potential changes during mast cell activation. Agents Actions (1991) 0.78
Insulin releasing effects of mastoparan and amphiphilic substance P receptor antagonists on RINm5F insulinoma cells. Mol Cell Biochem (1992) 0.78
Molecular basis for cellular effects of naturally occurring polyamines. Agents Actions (1991) 0.78
The use of the potential-sensitive fluorescent probe bisoxonol in mast cells. Biochim Biophys Acta (1991) 0.78
M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity? J Recept Signal Transduct Res (1997) 0.77
Inhibition of GTPase activity of Gi proteins and decreased agonist affinity at M2 muscarinic acetylcholine receptors by spermine and methoctramine. Br J Pharmacol (1999) 0.77
Involvement of B2 receptors in the bradykinin-induced relaxation of guinea-pig isolated trachea. Br J Pharmacol (1995) 0.77
Structural requirements for neuropeptide Y in mast cell and G protein activation. Eur J Pharmacol (1995) 0.77
Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance. Plasmid (1997) 0.77
Glucocorticoids inhibit the bradykinin B2 receptor increase induced by interleukin-1beta in human bronchial smooth muscle cells. Eur J Pharmacol (1998) 0.77
Contractile activity of the N-acylated C-terminal part of substance P7-11 in guinea pig trachea. Effect of epithelium removal. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.77
Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions. Mol Pharmacol (1990) 0.76
The M2 muscarinic receptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.76
Receptor-independent activation of mast cells by bradykinin and related peptides. Trends Neurosci (1993) 0.76
Nedocromil sodium inhibits IgE- and IgG-related antigen-induced contraction in guinea-pig trachea. Int Arch Allergy Appl Immunol (1989) 0.76
Glucocorticoids increase bradykinin B2 receptor gene transcription in cultured guinea-pig tracheal smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.76
Glucocorticoid modulation of muscarinic and beta-adrenergic receptors in guinea pig lung. Fundam Clin Pharmacol (1997) 0.75
Potential anti-anaphylactic activity of clenbuterol, a beta-agonist with calcium antagonist properties. Agents Actions (1985) 0.75
Inhibition of antigen-induced histamine release from rat mast cells by a cyclic GMP-phosphodiesterase inhibitor and sodium nitrite. Agents Actions (1981) 0.75
[Not Available]. Rev Hist Am Fr (1977) 0.75
Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance. Plasmid (1998) 0.75
The sensitivity to Zn2+ discriminates between typical and atypical mast cells. Agents Actions (1990) 0.75
[Not Available]. Ann Demogr Hist (Paris) (1988) 0.75
Energy requirement for calcium uptake by thymus lymphocytes. FEBS Lett (1978) 0.75
Membrane phospholipid polar heads influence the coupling of M2 muscarinic receptors to G proteins. Neurochem Res (1988) 0.75
[Bronchial peptidergic control and concepts of neurogenic inflammation]. Rev Pneumol Clin (1989) 0.75
[Active transport of calcium in thymocytes]. C R Seances Soc Biol Fil (1975) 0.75